Millipore Sigma Vibrant Logo
Home>Events>APGI Workshop: Overcoming Challenges of Insoluble APIs in Solid Oral Dosage Forms
Back to previous page

APGI Workshop

In partnership with Gattefossé
Merck in partnership
with Gattefossé.


APGI Workshop: Overcoming Challenges of Insoluble APIs in Solid Oral Dosage Forms - Capsules

APGI Workshop: Overcoming Challenges of Insoluble APIs in Solid Oral Dosage Forms- Pint Glass

Overcoming Challenges of Insoluble APIs in Solid Oral Dosage Forms:
Formulating with innovative technologies and high performance materials.

Join us at the CNAM in Paris to learn with experts and share knowledge on successful approaches to resolve the challenges of insoluble APIs.

In the morning the expert speakers will deliver a well-rounded programme covering:

  • A leading drug developers’ insight of a successful route map from API profiling to clinical development and the decisions and strategies applied
  • Science-based talks on the properties of innovative materials and defining the right formulation strategy
  • Understanding how micronization should be applied to improve API solubility

In the afternoon case studies show how the science converts to practice and how to use innovative materials to their best advantage.

These interactive sessions are the opportunity to raise any gritty question to the experts.

May 24, 2016 Conservatoire des Arts et des Métiers (CNAM)
292 rue Saint-Martin, 75141 Paris
Timing: 9:00 – 16:30
Rooms: L ecture Amphithéatre C l’Abbé Grégoire CNAM
Case study group A in room la salle des conseils
Download Brochure		 Registration
Agenda*
9:00 – 9:20 Welcome
9:20 – 10:00 Poor soluble small molecule, from biopharmaceutical profiling to an appropriate dosage form for clinical development - an industrial perspective
Dr. Alexandre Gil, Head of Early Development, Sanofi
10:00 – 10:40 Liquid and solid lipid-based formulations for solubility enhancement
Dr. Vincent Jannin, Pharmaceutical Reseach Director, Gattefossé
10:40 – 11:00 Coffee break
11:00 – 11:40 Solving bioavailability challenges with innovative and flexible materials
Dr. Dieter Lubda, Director R&D Bioavailability, Merck
11:40 – 12:20 Co-micronisation: innovative technology to enhance oral bioavailability of poorly water soluble APIs
Dr. Jerome Hecq, Head of Pharmaceutical Development, Bertin Pharma
12:20 – 12:30 Questions
12:20 – 14:00 Lunch – CNAM’s restaurant
Case study sessions: Two groups with a rotation
14:00 – 15:00 Gattefossé case studies: designing lipid-based formulations based on API properties - theory into practice
Dr. Vincent Jannin, Gattefossé
15:00 – 15:15 Break
15:15 – 16:15 Merck case studies: understanding API properties to design effective solubility solutions
Dr. Dieter Lubda, Merck
16:15 – 16:30 Wrap-up, feedback forms and closure

*Agenda subject to change.